Laboratory visual for the photoageing and extracellular matrix edition of Muzi Recommendations
RecommendationsDaily Literature Watch
Editorial summary

An English reading guide to 6 source papers selected by the existing GreenDee science workflow, with emphasis on photoageing and extracellular matrix, moisturisation and skin barrier and preservation and microbiology. No new literature search was performed for this GreenZn edition.

6Papers retained
6Full texts reviewed
6Journals represented
12Located evidence points
Reading map

Three signals to carry into development

2 papers

photoageing and extracellular matrix

Identify the study model, exposure, comparator, endpoint and limitation before transferring the result to an ingredient or formulation decision.

2 papers

moisturisation and skin barrier

Identify the study model, exposure, comparator, endpoint and limitation before transferring the result to an ingredient or formulation decision.

2 papers

preservation and microbiology

Identify the study model, exposure, comparator, endpoint and limitation before transferring the result to an ingredient or formulation decision.

Evidence layer

What this edition covers

The GreenDee source workflow screened 6 candidates and retained 6 papers with located evidence for this edition. The reading set spans photoageing and extracellular matrix, moisturisation and skin barrier and preservation and microbiology.

6 papers were recorded as full-text reviewed. The count describes the source workflow status; it is not a quality score and does not establish that every result is transferable to a cosmetic ingredient, formula or market claim.

Evidence layer

How international teams should use the list

Use each paper as a route to a testable question: identify the study model, exposure conditions, measured endpoint, comparator and limitation before discussing commercial relevance.

Formulation teams can translate a relevant paper into a small comparison matrix. Marketing and sales teams should retain the distinction between a published research signal, an ingredient specification, finished-product evidence and an authorised market claim.

Evidence layer

photoageing and extracellular matrix

Read this group as a connected set of questions about photoageing and extracellular matrix.

Compare study models, measured endpoints and limitations before treating results as comparable. A shared theme does not establish agreement, conflict or a finished-product claim.

01
Pharmaceuticals (Basel, Switzerland) · 2026

In Vitro and Clinical Dermatological Effects of Rubus crataegifolius Fruit Extracts on Human Fibroblasts and Keratinocytes.

skin biologyoxidative stress and inflammationextracellular matrix and ageing

Why it matters

A hydration change still needs a vehicle comparison.

What the study found

Twelve healthy women received a formulation containing 20 µg/mL Rubus crataegifolius fruit extract and 1% 1,2-hexanediol. Hydration readings changed over a 24-hour observation window.

What needs separating

There was no vehicle-treated or untreated control site. The change therefore cannot be attributed to the extract alone. Three instrument readings per time point are not three independent participants.

A useful next test

The proposed contribution of multiple annotated compounds remains an interpretation. Matched vehicle controls and measured batch composition would be useful next steps; the study does not establish a current commercial dose, long-term benefit or comprehensive safety.

Evidence boundaries

Source locations: 4.11. Clinical Study of Hydration / p-44; 2.6. Clinical Efficacy of RC Extracts on Skin Hydration / p-23.

DOI 10.3390/ph19091451 ↗
02
Pharmaceutical biology · 2026

A proposed evaluation of new approach methodologies for dermal toxicity assessment of botanicals.

skin biologytopical deliveryformulation materialssafety assessment

Why it matters

Efficacy signals and safety evidence answer different questions.

What the study found

This narrative review proposes reference botanicals and candidate methods for evaluating irritation, sensitization and phototoxicity in complex botanical mixtures.

What needs separating

Testing the selected materials and assessing assay performance are described as subsequent work. The review is not a completed validation study and does not demonstrate systematic bias in every existing method.

A useful next test

A useful next step is to define the actual material, batch composition and intended exposure before selecting appropriate endpoints. This paper does not establish the safety of the Rubus test material or a current GreenDee product.

Evidence boundaries

Source locations: Abstract / p-2; Conclusions / p-108.

DOI 10.1080/13880209.2026.2717803 ↗
Evidence layer

Three separate questions

Observation

Short-term before-and-after readings

Control

Could the matched vehicle explain the change?

Safety

Composition, exposure and suitable assays

Original GreenDee measurement questions, not experimental data or a demonstrated causal chain.

Source study 1 · Source study 2

Evidence layer

moisturisation and skin barrier

Read this group as a connected set of questions about moisturisation and skin barrier.

Compare study models, measured endpoints and limitations before treating results as comparable. A shared theme does not establish agreement, conflict or a finished-product claim.

03
Pharmaceutics · 2026

Design and Optimization of Self-Nanoemulsifying Drug Delivery Systems to Enhance the Anti-Inflammatory Efficacy of Derris scandens (Roxb.) Benth. Extract.

skin biologyoxidative stress and inflammationtopical deliveryformulation materials

Why it matters

A blank carrier changes the readout; simple subtraction is not attribution.

What the study found

The blank nanoemulsion also changed nitrite accumulation in LPS-stimulated cells, an indirect readout of nitric oxide production. This makes carrier controls essential but does not establish additivity or synergy.

What needs separating

The reported IC50 values concern cell viability: 31.57 µg/mL for free extract and 4735 µg/mL of formulation, equivalent to 94.70 µg/mL extract. They are not anti-inflammatory potency values. A separate NO comparison included 40 µg/mL extract equivalents, so matched-condition viability must be checked before attributing differences.

A useful next test

Compare measured exposure, carrier dose, treatment duration, viability and the target endpoint together. Release was not directly measured; these results do not establish superior skin efficacy or a current commercial-product claim.

Evidence boundaries

Source locations: 3.6. Cytotoxicity and In Vitro Anti-Inflammatory Activity / p-57; 3.6. Cytotoxicity and In Vitro Anti-Inflammatory Activity / p-58.

DOI 10.3390/pharmaceutics18091188 ↗
04
Frontiers in molecular biosciences · 2026

In vitro antioxidant and collagen restoration activities of a standardized Centella asiatica L. extract formulated with phospholipids.

skin biologyoxidative stress and inflammationextracellular matrix and ageingtopical deliveryformulation materials

Why it matters

Equal extract mass does not mean equal active exposure.

What the study found

The phospholipid-associated and unformulated Centella materials had total-triterpene specification minima of 13% and 45%. Assay concentrations were expressed as dry-extract equivalents, without triterpene normalization.

What needs separating

Preparation included centrifugation and filtration. Actual dissolved exposure cannot be calculated reliably from specification minima alone. The fibroblasts came from one donor.

A useful next test

Measured recovery before and after preparation, matched active doses, a blank carrier and multiple donors could help separate explanations. The study does not validate a current biotransformed Centella product, its batch consistency or finished-formulation efficacy.

Evidence boundaries

Source locations: Centella asiatica L. extract / p-7; NHDF cell culture / p-8.

DOI 10.3389/fmolb.2026.1832045 ↗
Evidence layer

Carrier, exposure and cell state

Materials

Free material, blank carrier and loaded system

Dose basis

Extract mass or measured active exposure?

Readouts

Match viability and the endpoint conditions

Original GreenDee measurement questions, not experimental data or a demonstrated causal chain.

Source study 1 · Source study 2

Evidence layer

preservation and microbiology

Read this group as a connected set of questions about preservation and microbiology.

Compare study models, measured endpoints and limitations before treating results as comparable. A shared theme does not establish agreement, conflict or a finished-product claim.

05
Microorganisms · 2026

In-Store Cosmetic Testers Harbour Resistant Bacteria: A Pilot Survey of Microbial Contamination and Antimicrobial Susceptibility in Portuguese Pharmacies.

microbiome and immunityformulation materials

Why it matters

Recovering bacteria from testers is not itself a preservative-failure diagnosis.

What the study found

Cultivable growth was found in 25 of 42 in-use testers from pharmacies in northern Portugal. Twelve of 33 characterized isolates met the study-specific operational multidrug-resistance definition. Products and isolates have different denominators.

What needs separating

No preservative-neutralization step was performed. Negative cultures cannot be treated as proof of absence, and preservative efficacy, cumulative handling and tester age were not assessed.

A useful next test

Follow-up work could validate neutralization and recovery while documenting packaging and use history. Antibiotic-resistance phenotypes do not demonstrate preservative tolerance, transfer to consumers or infection.

Evidence boundaries

Source locations: 4. Discussion / p-43; 4. Discussion / p-55.

DOI 10.3390/microorganisms14092120 ↗
06
Molecules (Basel, Switzerland) · 2024

New Natural and Sustainable Cosmetic Preservative Based on Sugarcane Straw Extract.

oxidative stress and inflammationmicrobiome and immunityformulation materialssafety assessmentoptics, colour and sensory science

Why it matters

The solvent is part of the antimicrobial comparison.

What the study found

The sugarcane straw study included solvent-only controls. In particular, 1,2-hexanediol contributed antimicrobial activity, so the mixed ingredient cannot be interpreted as an extract-only effect.

What needs separating

Challenge testing concerned two specific emulsion systems. The article uses inconsistent w/v and v/v notation for the reported challenge addition level; we therefore do not calculate an active dose or recommend a formulation percentage from it.

A useful next test

A follow-up should define the concentration basis, match solvent controls and verify neutralization and microbial recovery in the target formula. MIC, challenge performance and in-use contamination answer different questions; their readouts cannot be directly converted or subtracted.

Evidence boundaries

Source locations: 2.2.2. Sugarcane Straw Extract-Based Ingredients / p-18; 2.3. Antimicrobial Effectiveness by USP 51 Challenge Test / p-20.

DOI 10.3390/molecules29163928 ↗
Evidence layer

Three windows, different questions

In-use survey

What can be recovered under the sampling conditions?

Ingredient assay

Growth in the specified strain and medium

Formula challenge

Counts over time after inoculation

Original GreenDee measurement questions, not experimental data or a demonstrated causal chain.

Source study 1 · Source study 2

Editorial and use boundary

This English edition is distilled from the already-published GreenDee paper list. It does not reproduce paper abstracts or full text, and it does not convert literature findings into ingredient efficacy, safety, regulatory or finished-product claims. Readers should review the cited source and validate the intended application.